Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Molecular Cancer Therapeutics|January 24, 2007
The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cellsWendy L Allen, Estelle G McLean, John Boyer, et al.Nature Communications|February 11, 2014
Large-scale solution synthesis of narrow graphene nanoribbonsTimothy H Vo, Mikhail Shekhirev, Donna A Kunkel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2010
Germline polymorphisms in genes involved in the IGF1 pathway predict efficacy of cetuximab in wild-type KRAS mCRC patientsThomas Winder, Wu Zhang, Dongyun Yang, et al.International Journal of Cancer|November 25, 2010
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinomaThomas Winder, Yan Ning, Dongyun Yang, et al.Cancer Chemotherapy and Pharmacology|January 12, 2010
A phase I/II trial of vorinostat in combination with 5-fluorouracil in patients with metastatic colorectal cancer who previously failed 5-FU-based chemotherapyPeter M Wilson, Anthony El-Khoueiry, Syma Iqbal, et al.International Journal of Cancer|July 22, 2010
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line modelsYan Ning, Philipp C Manegold, Young Kwon Hong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2011
Common cancer stem cell gene variants predict colon cancer recurrenceArmin Gerger, Wu Zhang, Dongyun Yang, et al.NPJ Breast Cancer|April 7, 2021
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancerCraig Davison, Roisin Morelli, Catherine Knowlson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2011
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancerArmin Gerger, Anthony El-Khoueiry, Wu Zhang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Polymorphisms in cyclooxygenase-2 and epidermal growth factor receptor are associated with progression-free survival independent of K-ras in metastatic colorectal cancer patients treated with single-agent cetuximabGeorg Lurje, Fumio Nagashima, Wu Zhang, et al.Pageof 4